VectorY
Amsterdam
About VectorY
VectorY is a fully integrated gene therapy company specializing in the development of novel therapeutics such as vectorized antibodies for both CNS and somatic disorders, with a particular emphasis on muscle diseases. It combines the therapeutic potential of antibodies and gene therapy to create long-term therapeutic solutions for large disease areas with significant unmet medical need. VectorY was founded in the Amsterdam Science Park in August 2020.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $175.6M
- Funding stage: Early Stage Venture
- Last round: Series A (Nov 2023)
- Website: vectorytx.com
- Phone: +31 20 226 8020
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/vectory-27107 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.